全文获取类型
收费全文 | 108462篇 |
免费 | 8443篇 |
国内免费 | 5010篇 |
专业分类
耳鼻咽喉 | 583篇 |
儿科学 | 1832篇 |
妇产科学 | 1307篇 |
基础医学 | 18334篇 |
口腔科学 | 2174篇 |
临床医学 | 8262篇 |
内科学 | 17526篇 |
皮肤病学 | 1564篇 |
神经病学 | 8866篇 |
特种医学 | 1726篇 |
外国民族医学 | 27篇 |
外科学 | 6571篇 |
综合类 | 18027篇 |
现状与发展 | 26篇 |
预防医学 | 5588篇 |
眼科学 | 1203篇 |
药学 | 13031篇 |
12篇 | |
中国医学 | 3168篇 |
肿瘤学 | 12088篇 |
出版年
2024年 | 246篇 |
2023年 | 1309篇 |
2022年 | 3133篇 |
2021年 | 4108篇 |
2020年 | 3274篇 |
2019年 | 2763篇 |
2018年 | 2633篇 |
2017年 | 3048篇 |
2016年 | 3362篇 |
2015年 | 4004篇 |
2014年 | 6352篇 |
2013年 | 6996篇 |
2012年 | 6555篇 |
2011年 | 7521篇 |
2010年 | 6090篇 |
2009年 | 6035篇 |
2008年 | 6204篇 |
2007年 | 6098篇 |
2006年 | 5487篇 |
2005年 | 5171篇 |
2004年 | 4385篇 |
2003年 | 3880篇 |
2002年 | 3102篇 |
2001年 | 2751篇 |
2000年 | 2402篇 |
1999年 | 2057篇 |
1998年 | 1818篇 |
1997年 | 1605篇 |
1996年 | 1339篇 |
1995年 | 1090篇 |
1994年 | 915篇 |
1993年 | 758篇 |
1992年 | 607篇 |
1991年 | 561篇 |
1990年 | 441篇 |
1989年 | 364篇 |
1988年 | 356篇 |
1987年 | 328篇 |
1986年 | 300篇 |
1985年 | 417篇 |
1984年 | 377篇 |
1983年 | 242篇 |
1982年 | 290篇 |
1981年 | 233篇 |
1980年 | 208篇 |
1979年 | 141篇 |
1978年 | 125篇 |
1977年 | 113篇 |
1976年 | 90篇 |
1975年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
《Mayo Clinic proceedings. Mayo Clinic》2019,94(7):1321-1329
Immune checkpoint inhibitors are molecules that increase the endogenous immune response against tumors. They have revolutionized the field of oncology. Since their initial approval for the treatment of advanced melanoma, their use has expanded to the treatment of several other advanced cancers. Unfortunately, immune checkpoint inhibitors have also been associated with the emergence of a new subset of autoimmune-like toxicities, known as immune-related adverse events. These toxicities differ depending on the agent, malignancy, and individual susceptibilities. Although the skin and colon are most commonly involved, any organ may be affected, including the liver, lungs, kidneys, and heart. Most of these toxicities are diagnosed by excluding other secondary infectious or inflammatory causes. Corticosteroids are commonly used for treatment of moderate and severe immune-related adverse events, although additional immunosuppressive therapy may occasionally be required. The occurrence of immune-related toxicities may require discontinuation of immunotherapy, depending on the specific toxicity and its severity. In this article, we provide a focused review to familiarize practicing clinicians with this important topic given that the use of immune checkpoint inhibitors continues to increase. 相似文献
13.
14.
15.
《Vaccine》2021,39(26):3498-3508
Adenovirus infections are a major cause of epidemic keratoconjunctivitis (EKC), which can lead to corneal subepithelial infiltrates and multifocal corneal opacity. In the current study, we investigated the use of an E1/E3-deleted adenovirus serotype 5 (Ad5) vector as a vaccine administered intramuscularly (IM) or intranasally (IN) against subsequent challenges with a luciferase-expressing Ad5 (Ad5-Luci) vector via eyedrop. We evaluated the adaptive immune response to Ad5 vector vaccination and confirmed a robust polyfunctional CD8 T cell response in splenic cells. Neutralizing Ad5 antibodies were also measured in the sera of vaccinated mice as well as Ad5 antibody in the eye wash solutions. Upon challenge with Ad5-Luci vector 8 weeks post the primary immunization, transduction was significantly reduced by > 70% in the vaccinated mice, which was slightly better in IM- vs. that in IN-vaccinated animals. Resistance to subsequent challenge was observed 10 months post primary IM vaccination, with sustained reduction up to 60% in the Ad5-Luci vector transduction. Passive immunization of naive mice with antisera from IM to vaccinated mice subsequently challenged with the Ad5-Luci vector resulted in approximately 40% loss in transduction efficiency. Furthermore, the mice that received IM immunization with or without CD8 T cell depletion showed > 40% and 70% reductions, respectively, in Ad8 genomic copies after Ad8 topical challenge. We conclude that Ad-vector vaccination successfully induced an adaptive immune response that prevented subsequent Ad transduction in the cornea and conjunctiva-associated tissues in a mouse model of adenovirus keratoconjunctivitis, and that both cellular and humoral immunity play an important role in preventing Ad transduction. 相似文献
16.
17.
18.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
20.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64